BioSpace News Archive

The Department of Defense awarded a contract valued at $14 million with Ology Bioservices Inc., a biologics contract development and manufacturing organization, to develop and manufacture a monoclonal antibody for treatment and prevention of infection with the COVID-19 virus.

Believes the Board, Which Has Presided Over Significant Value Destruction in Recent Years, Has Asked Stockholders to Take an Unnecessary Risk Without Offering a Compelling Rationale

Affinity Health Partners, a rural health system owner and operator announced it is bringing a point of care COVID-19 test to its facilities and network partners facilities in April.

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), today announced topline results from its Phase 3, multicenter, randomized, double-blind, placebo-controlled NODE-301 trial of its investigational new drug, etripamil nasal spray, the Company’s novel short-acting calcium channel blocker, in patients with paroxysmal supraventricular tachycardia (PSVT).

ResMed (NYSE: RMD) (ASX: RMD) has released the following statement from CEO Mick Farrell regarding the evolving coronavirus disease (COVID-19) outbreak:

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by dysregulated gene expression, today reported its corporate and financial results for the fourth quarter and full-year ended December 31, 2019.

Moberg Pharma AB (publ) announces today that the company has entered into a convertible note agreement with Nice & Green S.A. (“N&G”), contingent on an authorization at an Extraordinary General Meeting. In December 2019, the company reported that the primary endpoint for MOB-015 was met in the North American phase 3 study.

Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) announces that it has opted to issue common shares to satisfy $107,560 owing to the holders of 10% secured debentures issued by Avivagen on March 28, 2019 and April 9, 2019 on account of an annual maintenance fee owing to such holders

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will be conducting a virtual presentation in conjunction with the Spring Investor Summit on Wednesday, March 25, 2020, at 1:50 p.m. ET.

Model N, Inc. announced that Rainmaker20 LIVE, a virtual event that empowered Model N customers to “know and grow” their top line revenue, exceeded online attendance estimates.